1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA IPO9 CTRPv2 pan-cancer AAC 0.22 6e-11
mRNA SUGP2 CTRPv2 pan-cancer AAC 0.22 6e-09
mRNA SMARCC1 CTRPv2 pan-cancer AAC 0.23 9e-10
mRNA ARHGAP19-SLIT1 CTRPv2 pan-cancer AAC 0.23 4e-09
mRNA KHDRBS1 CTRPv2 pan-cancer AAC 0.23 2e-11
mRNA SFPQ CTRPv2 pan-cancer AAC 0.23 4e-11
mRNA BEND3 CTRPv2 pan-cancer AAC 0.23 3e-11
mRNA PRR36 CTRPv2 pan-cancer AAC 0.23 1e-11
mRNA NASP CTRPv2 pan-cancer AAC 0.23 2e-12
mRNA ARHGAP45 CTRPv2 pan-cancer AAC 0.23 6e-07
Download CSV